Cargando…

Comparison of gastrointestinal side effects from different doses of azithromycin for the treatment of gonorrhoea

OBJECTIVES: Azithromycin is commonly used to treat Neisseria gonorrhoeae. We compared its gastrointestinal side effects using 1 g single, 2 g single or 2 g split (i.e. 1 g plus 1 g 6–12 h later) dosing, representing our clinic’s changing guidelines over the study period. METHODS: We recruited consec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ong, Jason J, Aguirre, Ivette, Unemo, Magnus, Kong, Fabian Y S, Fairley, Christopher K, Hocking, Jane S, Chow, Eric P F, Tieosapjaroen, Warittha, Ly, Jenny, Chen, Marcus Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244214/ https://www.ncbi.nlm.nih.gov/pubmed/35411400 http://dx.doi.org/10.1093/jac/dkac118

Ejemplares similares

Kissing, fellatio, and analingus as risk factors for oropharyngeal gonorrhoea in men who have sex with men: A cross-sectional study
por: Tran, Julien, et al.
Publicado: (2022)

Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
por: Gianecini, Ricardo Ariel, et al.
Publicado: (2021)

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022
por: Pleininger, Sonja, et al.
Publicado: (2022)

Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
por: Terkelsen, David, et al.
Publicado: (2017)

Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge
por: Unemo, Magnus
Publicado: (2015)

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016
por: Day, Michaela J., et al.
Publicado: (2018)

Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) – study protocol for non-randomised clinical trial
por: Kong, Fabian Y S, et al.
Publicado: (2022)

Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men
por: Kong, Fabian Y. S., et al.
Publicado: (2017)

Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015
por: Cole, Michelle J., et al.
Publicado: (2017)

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018
por: Eyre, David W, et al.
Publicado: (2018)

Gonorrhoea: a systematic review of prevalence reporting globally
por: Whelan, Jane, et al.
Publicado: (2021)

Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019
por: Day, Michaela J., et al.
Publicado: (2022)

An open-label, parallel-group, randomised controlled trial of antiseptic mouthwash versus antibiotics for oropharyngeal gonorrhoea treatment (OMEGA2)
por: Chow, Eric P. F., et al.
Publicado: (2020)

Molecular Diagnostics for Gonorrhoea: Implications for Antimicrobial Resistance and the Threat of Untreatable Gonorrhoea
por: Low, Nicola, et al.
Publicado: (2014)

Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic
por: Xu, Xianglong, et al.
Publicado: (2023)

Complete Reference Genome Sequence of the Extensively Drug-Resistant Strain Neisseria gonorrhoeae AT159, with Ceftriaxone Resistance and High-Level Azithromycin Resistance, Using Nanopore Q20+ Chemistry and Illumina Sequencing
por: Golparian, Daniel, et al.
Publicado: (2022)

High prevalence of rectal gonorrhoea among men reporting contact with men with gonorrhoea: Implications for epidemiological treatment
por: Dutt, Krishneel, et al.
Publicado: (2015)

Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018
por: Golparian, Daniel, et al.
Publicado: (2018)

Systematic Review and Meta-Analysis of Doxycycline Efficacy for Rectal Lymphogranuloma Venereum in Men Who Have Sex with Men
por: Leeyaphan, Charussri, et al.
Publicado: (2016)

Persistence of Mycoplasma genitalium Following Azithromycin Therapy
por: Bradshaw, Catriona S., et al.
Publicado: (2008)

Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed
por: Unemo, Magnus, et al.
Publicado: (2017)

Sustained Transmission of Neisseria gonorrhoeae Strains with High-Level Azithromycin Resistance (MIC ≥ 256 μg/mL) in Argentina, 2018 to 2022
por: Gianecini, Ricardo Ariel, et al.
Publicado: (2023)

Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract
por: Craig, Andrew P, et al.
Publicado: (2015)

Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS)
por: Vodstrcil, Lenka A., et al.
Publicado: (2017)

Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae?
por: Golparian, Daniel, et al.
Publicado: (2019)

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA
por: Papp, John R., et al.
Publicado: (2017)

In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?
por: Jacobsson, Susanne, et al.
Publicado: (2019)

Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012–2014 in Karachi, Pakistan
por: Jabeen, Kauser, et al.
Publicado: (2016)

Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009–2019
por: Aniskevich, Aliaksandra, et al.
Publicado: (2021)

Clinical presentation of asymptomatic and symptomatic women who tested positive for genital gonorrhoea at a sexual health service in Melbourne, Australia
por: Martín-Sánchez, Mario, et al.
Publicado: (2020)

Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary
por: Brunner, Alexandra, et al.
Publicado: (2016)

Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021
por: Selb, Regina, et al.
Publicado: (2021)

Antibiotic resistance and NG-MAST sequence types of Neisseria gonorrhoeae isolates in Poland compared to the world
por: Mlynarczyk-Bonikowska, Beata, et al.
Publicado: (2018)

Genetic variation regulates the activation and specificity of Restriction-Modification systems in Neisseria gonorrhoeae
por: Sánchez-Busó, Leonor, et al.
Publicado: (2019)

Trends and differences in sexual practices and sexually transmitted infections in men who have sex with men only (MSMO) and men who have sex with men and women (MSMW): a repeated cross-sectional study in Melbourne, Australia
por: Martín-Sánchez, Mario, et al.
Publicado: (2020)

Trends and Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018
por: Williamson, Deborah A., et al.
Publicado: (2019)

Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada
por: Martin, I., et al.
Publicado: (2016)

Access to HIV Antiretroviral Therapy among People Living with HIV in Melbourne during the COVID-19 Pandemic
por: Lee, Dooyeon, et al.
Publicado: (2021)

Clinical presentation of asymptomatic and symptomatic heterosexual men who tested positive for urethral gonorrhoea at a sexual health clinic in Melbourne, Australia
por: Martín-Sánchez, Mario, et al.
Publicado: (2020)

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011
por: Olsen, Birgitta, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vvd9r418eiloarfp348r9pbtl9